The Patent Finder

Phasebio Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Phasebio Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Phasebio Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,700,598Modified Vasoactive Intestinal Peptides
In force
 · High confidence
In forceHigh confidence
US 10,940,182Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
In force
 · High confidence
In forceHigh confidence
US 9,561,262Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
In force
 · High confidence
In forceHigh confidence
US 9,919,032A Method for Administering a Sustained Release Formulation
In force
 · High confidence
In forceHigh confidence
US 11,052,132Methods and Compositions for Treating Cystic Fibrosis
In force
 · High confidence
In forceHigh confidence
US 10,722,590Elp Fusion Proteins for Controlled and Sustained Release
In force
 · High confidence
In forceHigh confidence
US 10,688,156Methods and Compositions for Treating Muscle Disease and Disorders
In force
 · High confidence
In forceHigh confidence
US 11,266,719Methods and Compositions for Treating Muscle Disease and Disorders
In force
 · High confidence
In forceHigh confidence
US 10,085,984Metalloenzyme Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
US 10,538,511Metalloenzyme Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
10 of 37 records shown.
Pro members see all 37.
Pro members: see all 37 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited